Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole effect on BMS-275183 pharmacokinetics in advanced malignancies
NL-OMON29734Not yet recruiting
- Sponsor
- Bristol Myers Squibb
- Start
- Nov 2006
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of bms-275183 and esomeprazole in Non-hematologic malignancy, sponsored by Bristol Myers Squibb. Primary endpoint: BMS-275183 pharmacokinetic parameters. Planned start Nov 2006; status: not yet recruiting.
02
Drugs
bms-275183esomeprazole
03
Conditions
Non-hematologic malignancy
Beyond the preview
Go deeper on NL-OMON29734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29734.